ReviewDiscover oncology2024

The therapeutic use of 177 Lu-PSMA-617 radioligand therapy in prostate cancer treatment: a review of literature and ongoing trials.

Alexander Konopnicki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.